



indices.She presently has a 2.5cm shortening on the
operated limb. Her last follow up at about 36 months
showed satisfactory hip stability by radiological
indices.
A 46 year old female sickle cell disease
patient (HbSS) presented with right hip pain since her
first pregnancy in 1979. She had an antalgic gait with
3.5cm of real length shortening. In 1986 she had a
subtrochanteric derotation osteotomy in a tertiary
facility, and an implant removal a year after. Her
condition did not improve and she eventually
developed a degenerative low back spondylosis
possibly from limb length inequality. Her other past
surgical history included appendicectomy in 1981
and bilateral tubal ligation in 1995. She had been
pregnant twice, both children are alive. She was
definitely overweight with a body weight of 100kg
for a 5feet height. The radiologic hip stage was Ficat
and Arlet's stage 4, with collapsed femoral head,
upward migration of the proximal femur with
formation of a false acetabulum (Figure 1).
She was admitted three weeks prior to
surgery for traction for soft tissue stretching to ease
surgery and general workup including heamatinics
that increased the haemoglobin level from 8.0gmldl
to 10.4gmldl. She eventually had an Omnifit (Stryker
Howmedica Osteonics) total hip prosthesis on her
right hip three weeks after admission using a lateral
approach. Due to proximal femoral sclerosis and
deformity she had an upper femoral split
necessitating a cerclage wiring (Figure 2). She was
on partial weight bearing eight weeks after surgery to
await bone healing and integration of the
hydroxyapatite implants. The total hospital stay was
35 days. She mobilizes within her house bearing full
weight, but partially weight bears when walking long
distances because of back pain from a pre-op severe
lumbar spondylosis.
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This is a report of two sickle cell patients (HbSS) with advanced osteoarthritis of the right hip. The patients
were in Ficat and Arlet's stage 3 and 4 respectively. Both were females aged 23 and 46 years and they had
uncemented hydroxyapatite coated omnifit (Stryker Howmedica Osteonics) total hip prosthetic replacement.
The results so far have been quite encouraging. The procedure is technically demanding, fraught with risks and
expensive but very useful. This is the first of such reports in Nigeria.
INTRODUCTION
Sickle cell disease is the most important single gene
disorder in West Africa . The combined prevalence
of haemoglobin S and C is about 2-3 percent, while
the sickle cell trait (HbAS) is about 25 percent in
Nigeria . Some of these patients develop
osteonecrosis of the femoral head because of the
peculiar blood supply of the femoral head which
makes it vulnerable to ischaemia from arterial cut
off, venous stasis, intravascular thrombosis,
intraosseous sinusoidal compression or a
combination of these factors which are common in
sicklers . The chronic inflammatory response,
biomechanical faults consequent upon head
collapse, predisposition to infections and other
illnesses predispose the joints to developing
osteoarthritis .
Management of the hip lesion in sicklers is
technically demanding because of the proximal
femoral sclerosis conferring ability to split easily
.A lot of orthopaedic surgeons in the advanced
countries including China and India are offering
these patients total hip arthroplasty even in the very
young . Workers are presently resorting to the
uncemented prosthesis, especially those coated with
hydroxyapatite because it is said to stimulate better
bone growth and also achieve higher shear strength
.It is also said to enhance gap healing, improve
bone ingrowth in osteoporotic bones and convert
fibrous tissue to bone. The important factor for long
term survival is that uncemented prosthesis provides
immediate stability to avoid implant macro-motion
and good surface characteristics to encourage bone
ingrowth. Another advantage is in revision since
most of the beneficiaries are relatively young people.
This is a report to highlight this modality of














Pre op Hip Status in the 46Year old
A 23-year-old female graduate, with sickle cell
disease (HbSS) presented with a 21 month history of
right hip pain. At presentation, she was limping, could
not straight leg raise without support because of pain,
although the range of motion of the hip was
acceptable. Disuse atrophy of the affected limb was
not significant. Radiograph of the hip revealed a Ficat
and Arlet's stage 3 avascular necrosis of the right
femoral head. There was loss of joint space,
irregularity of the articular surfaces and vacuolization
and subchondral cysts of the femoral head (Figure 3).
She was admitted 12 days prior to surgery for
preoperative workup including her haemoglobin level
which increased to 10.8 . She had an Omnnifit
(Stryker Howmedica Osteonics) total hip prosthesis
through the lateral approach on 12/12/03 (Figure 4).
She is already mobilizing full weight bearing with no
hip pain. Her last follow up was at 30 months post
operatively with an absolutely stable hip joint.
Figure 1:
gmldl
Figure 2: Hip Replacement in the 46Year Old
Figure 3:
Figure 4:
Pre op Hip Status in 23Years Old
Hip Replacement in the 23Year Old
DISCUSSION
Avascular necrosis of the head of femur and severe
osteoarthritis of the hip joint are common
complications of sickle cell disease . Several
treatment modalities have been tried. These include
conservative antiarthritic drugs in combination with
chondroitin sulphate and glucosamine, hip fusion,
hemiarthroplasty, to total hip replacement .
Currently, it appears more workers prefer the
uncemented total hip arthroplasty . This is probably
more advantageous since reoperation (when the life
span of the prosthesis expires or in an event of a
complication) is simpler when compared to a
cemented replacement . Arthroplasty increases hip
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The advent of hydroxyapatite coating is of
advantage as it encourages bone ingrowth, gap
healing in osteoporotic bones and conversion of
fibrous tissues into bone . The uncemented hip is
also said to be advantageous as its fixation is instant
preventing macro motion between the acetabular
cup and the bone .This module includes a cup, an
insert, femoral head/stem components.
Our patients were quite young; one of them being
twenty three years. Launary et al even
recommended this mode of treatment for adolescent
sicklers .
From this limited experience we emphasise that a
preoperative workup should include haematinics
and antimalarials. We propose a minimal
haemoglobin level of 10 ; the use of
antithrombotic drugs, (we used vasoprin 75
for both patients). At surgery we preferred spinal
anaes thesia , augmented with ke tamine
hydrochloride in the course of surgery. A familiar
approach to the hip to be used. The use of a
diathermy is very helpful and a tube drain







complications include longitudinal split of the
proximal femur and early acetabular protrusion in
hemiresurfaced hips .
In conclusion, this preliminary report highlights an
additional possibility to the treatment of arthritic
hips in our sickler population and the very young
with osteoarthritic changes of the hip joint.
Although this procedure is technically demanding
(in acquisition and cost), its advantages far
outweigh the possible complications that may arise.
Despite the unavailability of image intensification
in many of our centers which aids in correct
placement of screws in the acetabulum and also
encourage minimal access, these cases can still be
managed well. To our knowledge, this is the first
report of the use of modular uncemented total hip
replacement in young people in Nigeria despite its
widespread use in some developing and developed
countries.
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